Fortrea Holdings Inc. Common Stock (FTRE)

About FTRE

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and…

Sector

Health Care

Industry

Medical Specialities

Employees

14,000

Website

www.fortrea.com/

Fundamentals

1-day range

$18.46$19.14

Market cap

$1.68B

P/E (trailing)

—

P/E (forward)

16.52

EPS (trailing)

$-0.91

Dividend yield

—

Beta

1.98

Avg. volume

1.45M

Forecasts

11 analyst ratings

Fortrea Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• FTRE

  Fortrea Holdings Inc. Common Stock

  $18.81

  ▼ 0.27%
  Market cap $1.68BP/E —
  $8.31$21.39
• PSNL

  Personalis Inc. Common Stock

  $17.08

  ▲ 1.67%
  Market cap $1.39BP/E —
• TRUP

  Trupanion Inc. Common Stock

  $29.64

  ▼ 0.03%
  Market cap $1.23BP/E 57.51
  $21.16$46.98
• LMRI

  Lumexa Imaging Holdings Inc. Common Stock

  $11.5

  ▼ 1.96%
  Market cap $1.10BP/E —
  $6.45$19.45
• CDNA

  CareDx Inc. Common Stock

  $49.73

  ▼ 5.02%
  Market cap $2.32BP/E 22.08
  $12.37$53.67
• CSTL

  Castle Biosciences Inc. Common Stock

  $33.57

  ▼ 2.03%
  Market cap $930.84MP/E —
  $17.72$44.28
• CLOV

  Clover Health Investments Corp. Class A Common Stock

  $4.22

  ▼ 0.24%
  Market cap $2.45BP/E —

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Drug Development Inputs & Services Stocks Q2 In Review: Fortrea (NASDAQ:FTRE) Vs Peers
  Yahoo · 8/15/2026
• This Healthcare Services Stock Has 37% Upside
  Yahoo · 8/13/2026
• Fortrea (FTRE) Gains Traction in Turnaround
  Yahoo · 8/11/2026
• Fortrea Holdings (FTRE) Beat Expectations, Is The Upside Already Priced In?
  Yahoo · 8/9/2026
• Will Fortrea’s (FTRE) Higher 2026 Revenue Guidance and CFO Shift Recast Its Investment Narrative?
  Yahoo · 8/9/2026
• Fortrea (FTRE) Q2 2026 Earnings Call Transcript
  Yahoo · 8/8/2026
• Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
  Yahoo · 8/6/2026
• Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last
  Yahoo · 8/4/2026

• Thakral Anshul · August 6, 2026 · Sale

  56.0K @ $18.06
• Thakral Anshul · August 6, 2026 · Sale

  55.9K @ $18.17
• Thakral Anshul · August 5, 2026 · Sale

  50.4K @ $19.28
• Thakral Anshul · August 5, 2026 · Sale

  49.5K @ $19.03
• Thakral Anshul · August 4, 2026 · Option Exercise

  416.7K
• MacHelle Sanders · August 3, 2026 · Sale

  9.7K @ $18.01
• Smith David Ross · August 3, 2026 · Grant

  15.8K
• Smith David Ross · July 20, 2026 · Option Exercise

  6.6K
• Morais Mark A. · June 10, 2026 · Sale

  4.7K @ $16.82
• Amrit Ray · June 10, 2026 · Grant

  12.9K
• Amrit Ray · June 10, 2026 · Option Exercise

  38.8K
• MacHelle Sanders · June 10, 2026 · Grant

  12.9K
• MacHelle Sanders · June 10, 2026 · Option Exercise

  38.8K
• Smith David Ross · June 10, 2026 · Grant

  12.9K
• Smith David Ross · June 10, 2026 · Option Exercise

  38.8K

Institutional Ownership

March 31, 2026

Total shares held

95.43M

Total value held

$873.60M

Institutional holders

323